Showing 4011-4020 of 10412 results for "".
Multiplexed 1,440 and 1,320 nm Laser for Chronic Photodamage
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/multiplexed-1-440-and-1-320-nm-laser-for-chronic-photodamage/19352/Dr. Bernstein discusses the benefits of a multiplexed dual wavelength non-ablative laser for treatment of photodamage.Take 5
https://practicaldermatology.com/columns/take-5/PD1108Take5-pdf/22623/Take 5
https://practicaldermatology.com/columns/take-5/pd1008_15-pdf/22639/Take 5
https://practicaldermatology.com/columns/take-5/PD0908take5-pdf/22649/Take 5
https://practicaldermatology.com/columns/take-5/PD0708take5-pdf/22663/Take 5
https://practicaldermatology.com/columns/take-5/PD0608Take5-pdf/22678/Take 5
https://practicaldermatology.com/columns/take-5/PD0508Take5-pdf/22691/Coding Checklist
https://practicaldermatology.com/topics/general-topics/PD1105Coding-pdf/22111/- Sensus Healthcare Appoints Dr. Mark Nestor as Clinical Directorhttps://practicaldermatology.com/news/20130830-sensus_healthcare_appoints_dr_mark_nestor_as_clinical_director/2459470/Mark Nestor, MD, PhD has been appointed as Clinical Director of Sensus Healthcare. Dr. Nestor will lead the company's efforts in the areas of training, education, and clinical research as Se
- Pulse Biosciences Scores CE Mark for CellFX Systemhttps://practicaldermatology.com/news/pulse-biosciences-scores-ce-mark-for-cellfx-system/2460666/Pulse Biosciences, Inc. received CE mark for the CellFXSystem. The Company can now proceed with its planned controlled launch of the CellFX System to medical practices within the European Union (EU) for the treatment of general dermatologic conditions, including sebaceous hyperplasia (S